MARQUES TIAGO (Chief Executive Officer) received a stock award from PASITHEA THERAPEUTICS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 4 awards
Filed: 11/28/2022ACC: 0001213900-22-075490
DirectorOfficer· Chief Executive Officer
Since Sep 2021
+9.21K
Net shares
Net buyer
$9.3K
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
9.21K acquired
Non-Derivative Transactions4
Common Stock
Direct
Shares
+5K
Price / share
$1.00
Trade value
$5K
% of position
0.6%
11/23/2022
810K→815K
Common Stock
Direct
Shares
+1K
Price / share
$1.03
Trade value
$1.03K
% of position
0.1%
11/23/2022
815K→816K
Common Stock
Direct
Shares
+1.21K
Price / share
$1.02
Trade value
$1.23K
% of position
0.1%
11/23/2022
816K→817.21K
Common Stock
Direct
Shares
+2K
Price / share
$1.03
Trade value
$2.06K
% of position
0.2%
11/25/2022
817.21K→819.21K
Total
Net shares
+9.21K
Net value
$9.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/23/2022 | A · Award | +5K | $1.00 | $5K | 0.6% | 810K | 815K |
| Common Stock Direct | 11/23/2022 | A · Award | +1K | $1.03 | $1.03K | 0.1% | 815K | 816K |
| Common Stock Direct | 11/23/2022 | A · Award | +1.21K | $1.02 | $1.23K | 0.1% | 816K | 817.21K |
| Common Stock Direct | 11/25/2022 | A · Award | +2K | $1.03 | $2.06K | 0.2% | 817.21K | 819.21K |
| Total | +9.21K | $9.32K | ||||||
Derivative Transactions0
No derivative transactions reported